There was a corresponding highly significant increase in both p300 and gp130 expression in anti-miR-142-treated versus non-targeting-vector-treated mice, providing further validation of these targets in vivo ( Fig 6D ).
← all excerpts
Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy.
1
—
—